✦ LIBER ✦

Acute abdomen due to endometriosis as a diagnostic and therapeutic challenge in the treatment of acute myelocytic leukemia

✍ Scribed by M. Karthaus; A. Prahst; R. G. Geissler; B. Hertenstein; F. Degenhardt; A. Ganser

Publisher: Springer
Year: 1997
Tongue: English
Weight: 178 KB
Volume: 74
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The treatment of acute myelocytic leukem

The treatment of acute myelocytic leukemia in patients 30 years of age and younger

✍ H. D. Preisler; M. Brecher; G. Browman; A. P. Early; I. R. Walker; A. Raza; A. F 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

The clonogenic assay as a reproducible i

The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemia

✍ Dr. George Browman; Jack Goldberg; Arlan J. Gottlieb; Harvey D. Preisler; Nozar 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

The GST deletions and NQO1*2 polymorphis

The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia

✍ Eva Barragan; Maria Collado; Jose Cervera; Guillermo Martin; Pascual Bolufer; Jo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 469 KB

Polymorphisms in transporter and phase I

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

✍ Phillip Müller; Nava Asher; Maya Heled; Sara Bar Cohen; Angela Risch; Deborah Ru 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Drug metabolism/disposition and transporter genes may influence predisposition or prognosis of AML (acute myeloid leukemia) patients. We analyzed polymorphisms in 3 transporters and 4 drug metabolism genes in 293 Israeli individuals (112 AML patients and 181 controls). We analyzed: ABCC3 (MRP3) C-21

A Phase II study of carboplatin as a tre

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow : A report of the Children's Cancer Group

✍ Lawrence J. Ettinger; Percy Ivy; Paul S. Gaynon; Alice G. Ettinger; Wen Liu-Mare 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 3 views

## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity

Comparison of idarubicin to daunomycin i

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group

✍ Feig, Stephen A.; Ames, Matthew M.; Sather, Harland N.; Steinherz, Laurel; Reid, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1003 KB

The outcome of children with acute lymphoblastic leukemia (ALL) and bone marrow relapse has been unsatisfactory largely because of failure to prevent subsequent leukemia relapses. Ninety-six patients were enrolled and received vincristine, prednisone, L-asparaginase, and an anthracycline as reinduc